NCT04642365 2025-05-21A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.Hoffmann-La RochePhase 1 Terminated49 enrolled 31 charts